Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human PTGFR Stable Cell Line

    [CAT#: S01YF-0923-KX10]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    PTGFR
    Target Family
    Prostanoid Family
    Target Protein Species
    Human
    Host Cell Type
    CHO-K1; HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    Reproductive Research; Ocular Research
    Related Diseases
    Ocular Hyperemia; Ocular Hypertension
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The prostaglandin (PG) group of receptors includes PTGFR, sometimes referred to as the prostaglandin F receptor (FP). PTGFR binds to prostaglandin F2α (PGF2α) and regulates its biological effects. It is thought to be the most effective therapeutic target out of the nine prostanoid receptors. Humans who use PTGFR receptor agonists on their eyelashes may have hyperpigmentation in nearby skin areas as a side effect. PTGFR receptor activation may be a practical way to improve skin pigmentation, according to studies. In addition, PGF2α restricts airways in both healthy and asthmatic people, and its presence in human sputum is associated with eosinophil levels in the same fluid. In terms of blood pressure, cardiac function, and atherosclerosis, PTGFR activation has pathologic effects on the cardiovascular system in animal models. The customized PTGFR stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Ryan

    I have always got fast and friendly response from Creative biolabs. Sep 05 2022

    chat Verified Customer

    chat Audrey

    I am happy for the service and the product. The web-page is easy to navigate in order to choose the product. Jun 24 2022

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 Activation of the PGF2α-PTGFR

    On postnatal day 16, Ptgfr mRNA expression was present in each retinal layer of normoxic and OIR mice. With isolectin B4-stained arteries in green, DAPI-stained nuclei in blue, and LCM isolation locations circled by white dashed circles, the left-hand figure shows representative cross-sections from OIR and normoxic retinas.

    Ref: Zhao, Yan, et al. "PGF2α facilitates pathological retinal angiogenesis by modulating endothelial FOS-driven ELR+ CXC chemokine expression." EMBO Molecular Medicine 15.1 (2023): e16373.

    Pubmed: 36511116

    DOI: 10.15252/emmm.202216373

    Research Highlights

    In order to better understand how intraocular pressure (IOP) response to latanoprost in POAG patients may be correlated with common single nucleotide polymorphisms (SNPs) in the AFAP1, GMDS, and PTGFR genes, this study looked into this possibility.
    Cui, X-J., A-G. Zhao, and X-L. Wang. "Correlations of AFAP 1, GMDS and PTGFR gene polymorphisms with intra-ocular pressure response to latanoprost in patients with primary open-angle glaucoma." Journal of clinical pharmacy and therapeutics 42.1 (2017): 87-92.
    Pubmed: 27862086   DOI: 10.1111/jcpt.12468

    For spermatogenesis and steroidogenesis, prostaglandins (PGs) and prostaglandin endoperoxide synthase (PTGS) are thought to be important.
    Körber, H., and S. Goericke-Pesch. "Expression of PTGS2, PGFS and PTGFR during downregulation and restart of spermatogenesis following GnRH agonist treatment in the dog." Cell and tissue research 375.2 (2019): 531-541.
    Pubmed: 30198052   DOI: 10.1007/s00441-018-2915-x

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare